Intelligence · Clinical Development
Pipeline search results
Programs matching “multiple-myeloma” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 167 pipeline programs matching "multiple-myeloma" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Belantamab mafodotin
GlaxoSmithKline
Multiple Myeloma
1 trial -
Bortezomib
Hospital Authority, Hong Kong
Multiple Myeloma
1 trial -
Carfilzomib
Amgen
Multiple Myeloma
2 trials -
Cilta-cel
Janssen Cilag International NV
Multiple Myeloma
1 trial -
Dara SC
Janssen Cilag International NV
Multiple Myeloma
1 trial -
Daratumumab
Janssen Cilag International NV
Multiple Myeloma
3 trials -
Dexamethasone
Amgen
Relapsed Multiple Myeloma
1 trial -
Etoposide
The First People's Hospital of Lianyungang
Multiple Myeloma
1 trial -
Fosaprepitant
The First People's Hospital of Lianyungang
Multiple Myeloma
1 trial -
HM16/047
Takeda
Multiple Myeloma
1 trial -
IGI, 10%
Takeda
Multiple Myeloma
1 trial -
Ixazomib
Takeda
Relapsed Multiple Myeloma
1 trial -
Ixazomib Citrate
Takeda
Multiple Myeloma
2 trials -
Linvoseltamab
Regeneron UK Limited
Multiple Myeloma (MM)
1 trial -
Linvoseltamab
Regeneron UK Limited
Multiple Myeloma
6 trials -
Linvoseltamab
Regeneron UK Limited
High Risk Smoldering Multiple Myeloma (HR-SMM)
1 trial -
Linvoseltamab
Regeneron UK Limited
Relapsed Refractory Multiple Myeloma (RRMM)
2 trials -
Linvoseltamab
Regeneron UK Limited
Relapsed and/or Refractory Multiple Myeloma (RRMM)
1 trial -
Melflufen
Oncopeptides AB (publ)
Multiple Myeloma
1 trial -
MyelomaXIV
Takeda
Multiple Myeloma
1 trial -
Panobinostat
Novartis Pharmaceuticals
Multiple Myeloma
1 trial -
Placebo
Takeda
Multiple Myeloma
1 trial -
Placebo, Velcade and dexamethasone
Centocor B.V.
Multiple Myeloma
1 trial -
Selinexor
Karyopharm Therapeutics Inc
Multiple Myeloma
12 trials
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.